Boston Scientific Corp (BSX)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,850,000 1,789,000 1,825,000 1,771,000 1,593,000 1,228,000 898,000 874,000 656,000 598,000 829,000 755,000 986,000 1,056,000 496,000 177,000 -139,000 3,705,000 3,986,000 4,287,000
Revenue (ttm) US$ in thousands 16,746,000 15,910,000 15,228,000 14,707,000 14,240,000 13,757,000 13,400,000 13,045,000 12,682,000 12,567,000 12,329,000 12,162,000 11,888,000 11,469,000 11,196,000 10,122,000 9,913,000 10,110,000 10,158,000 10,786,000
Net profit margin 11.05% 11.24% 11.98% 12.04% 11.19% 8.93% 6.70% 6.70% 5.17% 4.76% 6.72% 6.21% 8.29% 9.21% 4.43% 1.75% -1.40% 36.65% 39.24% 39.75%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,850,000K ÷ $16,746,000K
= 11.05%

The net profit margin of Boston Scientific Corp has fluctuated over the specified timeframe. Starting at a high of 39.75% in March 2020, the margin experienced a significant decline to -1.40% by December 2020, indicating a period of unprofitability for the company. However, Boston Scientific Corp was able to improve its performance steadily thereafter, with the net profit margin increasing consistently to reach 11.05% by December 2024. This recovery suggests that the company implemented effective strategies to enhance profitability and efficiency in its operations over the analyzed period. Overall, the positive trend in the net profit margin demonstrates Boston Scientific Corp's ability to generate profits relative to its total revenue, reflecting a strengthening financial performance.


See also:

Boston Scientific Corp Net Profit Margin (Quarterly Data)